Hancock Whitney’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.7M Sell
474,193
-9,809
-2% -$572K 0.5% 50
2025
Q4
$26.1M Buy
484,002
+6,509
+1% +$313K 0.47% 55
2025
Q3
$21.5M Buy
477,493
+146,080
+44% +$6.82M 0.39% 74
2025
Q2
$15.3M Buy
331,413
+10,369
+3% +$509K 0.29% 93
2025
Q1
$19.6M Sell
321,044
-1,071
-0.3% -$62.4K 0.64% 36
2024
Q4
$18.2M Buy
322,115
+3,107
+1% +$174K 0.58% 39
2024
Q3
$16.5M Buy
319,008
+294,717
+1,213% +$13.8M 0.53% 40
2024
Q2
$1.01M Sell
24,291
-264
-1% -$11.8K 0.03% 300
2024
Q1
$1.33M Buy
24,555
+1,365
+6% +$69.5K 0.05% 257
2023
Q4
$1.19M Sell
23,190
-3,990
-15% -$209K 0.04% 279
2023
Q3
$1.58M Sell
27,180
-681
-2% -$41.7K 0.07% 210
2023
Q2
$1.78M Buy
27,861
+1,184
+4% +$79.4K 0.07% 211
2023
Q1
$1.85M Buy
26,677
+1,345
+5% +$94.9K 0.07% 214
2022
Q4
$1.82M Sell
25,332
-1,887
-7% -$142K 0.07% 222
2022
Q3
$1.94M Sell
27,219
-34
-0.1% -$2.47K 0.08% 198
2022
Q2
$2.1M Buy
27,253
+334
+1% +$25.4K 0.08% 190
2022
Q1
$1.97M Buy
26,919
+163
+0.6% +$10.9K 0.07% 231
2021
Q4
$1.67M Sell
26,756
-199
-0.7% -$11.7K 0.05% 270
2021
Q3
$1.6M Sell
26,955
-1,251
-4% -$82.4K 0.06% 267
2021
Q2
$1.89M Sell
28,206
-1,692
-6% -$110K 0.06% 292
2021
Q1
$1.89M Sell
29,898
-3,902
-12% -$243K 0.06% 285
2020
Q4
$2.1M Sell
33,800
-765
-2% -$47K 0.07% 255
2020
Q3
$2.08M Sell
34,565
-937
-3% -$56.4K 0.08% 211
2020
Q2
$2.09M Buy
35,502
+8,695
+32% +$520K 0.08% 213
2020
Q1
$1.5M Sell
26,807
-20,615
-43% -$1.26M 0.06% 295
2019
Q4
$3.04M Buy
47,422
+6,308
+15% +$361K 0.1% 235
2019
Q3
$2.08M Buy
41,114
+16,696
+68% +$785K 0.07% 288
2019
Q2
$1.11M Sell
24,418
-1,978
-7% -$92.1K 0.04% 440
2019
Q1
$1.26M Sell
26,396
-8,926
-25% -$445K 0.04% 419
2018
Q4
$1.84M Buy
35,322
+2,615
+8% +$141K 0.06% 309
2018
Q3
$2.03M Buy
32,707
+10,228
+46% +$607K 0.06% 330
2018
Q2
$1.24M Buy
22,479
+15
+0.1% +$810 0.06% 293
2018
Q1
$1.42M Buy
22,464
+840
+4% +$54K 0.06% 268
2017
Q4
$1.32M Buy
21,624
+14,242
+193% +$891K 0.05% 307
2017
Q3
$471K Sell
7,382
-900
-11% -$52.6K 0.02% 436
2017
Q2
$462K Buy
8,282
+670
+9% +$36.5K 0.02% 442
2017
Q1
$414K Buy
7,612
+55
+0.7% +$3.02K 0.02% 456
2016
Q4
$441K Sell
7,557
-122
-2% -$6.67K 0.02% 459
2016
Q3
$415K Sell
7,679
-36,735
-83% -$2.36M 0.02% 453
2016
Q2
$3.27M Sell
44,414
-18,693
-30% -$1.32M 0.14% 176
2016
Q1
$4.03K Sell
63,107
-2,680
-4% -$169K 0.17% 163
2015
Q4
$4.53M Buy
65,787
+54,607
+488% +$3.61M 0.19% 158
2015
Q3
$662K Sell
11,180
-10,119
-48% -$642K 0.03% 382
2015
Q2
$1.37M Hold
21,299
0.05% 252
2015
Q1
$1.37M Buy
21,299
+12,412
+140% +$777K 0.05% 252
2014
Q4
$525K Sell
8,887
-28
-0.3% -$1.58K 0.02% 407
2014
Q3
$456K Sell
8,915
-532
-6% -$26.6K 0.02% 410
2014
Q2
$458K Sell
9,447
-100
-1% -$4.93K 0.02% 415
2014
Q1
$496K Sell
9,547
-455
-5% -$24.2K 0.02% 376
2013
Q4
$531K Sell
10,002
-218
-2% -$11.1K 0.02% 342
2013
Q3
$473K Sell
10,220
-230
-2% -$10.1K 0.02% 364
2013
Q2
$467K Buy
+10,450
New +$454K 0.02% 372

Other funds holding BMY

Hancock Whitney's BMY Position: Q1 2026 in Review

Hancock Whitney reduced its Bristol-Myers Squibb (BMY) stake by 2% in Q1 2026, selling an estimated $572K and leaving 474,193 shares worth $28.7M. The position accounts for 0.5% of the portfolio, ranked #50.

Hancock Whitney first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Hancock Whitney held 474,193 shares of Bristol-Myers Squibb worth $28.7M as of Q1 2026.
  • Hancock Whitney sold 9,809 Bristol-Myers Squibb shares in Q1 2026, an estimated $572K.
  • Bristol-Myers Squibb made up 0.5% of Hancock Whitney's portfolio in Q1 2026, its #50 holding.
  • Hancock Whitney first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Hancock Whitney's 13F filing for Q1 2026, filed 15 May 2026.